How we have learned about the complexity of physiology, pathobiology and pharmacology of bile acids and biliary secretion

World Journal of Gastroenterology

Volumn 14, Issue 37, 2008, Pages 5617-5619

  Marin, Jose J G ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Bile flow; Cholestasis; Hepatocyte; Liver; Transport

Indexed keywords

BILE ACID SYNTHESIS; BILE FLOW; BILE SECRETION; CHOLESTASIS; EDITORIAL; ENTEROHEPATIC CIRCULATION; HUMAN; MEMBRANE TRANSPORT; ANIMAL; BILE; BILIARY TRACT DISEASE; HEPATOBILIARY SYSTEM; INTESTINE; LIVER; METABOLISM; PATHOPHYSIOLOGY; SECRETION;

BILE ACID; BILE ACID BINDING PROTEINS; CARRIER PROTEIN; MEMBRANE PROTEIN;

ANIMALS; BILE; BILE ACIDS AND SALTS; BILIARY TRACT; BILIARY TRACT DISEASES; CARRIER PROTEINS; ENTEROHEPATIC CIRCULATION; HUMANS; INTESTINES; LIVER; MEMBRANE GLYCOPROTEINS;

EID: 63449136525     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.14.5617     Document Type: Editorial

References (51)

1. Esteller A, Lopez MA. The effect of secretin and cholecystokinin-pancreozymin on the secretion of bile in the anaesthetized rabbit. Q J Exp Physiol Cogn Med Sci 1977; 62: 353-359
2. Schiff MI. Gallenbildung, abhangig von der Aufsangung der Gallenstoffe. Arch Ges Physiol Menschen Thiere 1870; 3: 598-613
3. Wheeler HO. Secretion of bile acids by the liver and their role in the formation of hepatic bile. Arch Intern Med 1972; 130: 533-541
4. Boyer JL. New concepts of mechanisms of hepatocyte bile formation. Physiol Rev 1980; 60: 303-326
5. Erlinger S. Physiology of bile flow. Prog Liver Dis 1972; 4: 63-82
6. Anwer MS, Hegner D. Importance of solvent drag and diffusion in bile acid-dependent bile formation: ion substitution studies in isolated perfused rat liver. Hepatology 1982; 2: 580-586
7. Hofmann AF, Small DM. Detergent properties of bile salts: correlation with physiological function. Annu Rev Med 1967; 18: 333-376
8. Carey MC, Small DM. The characteristics of mixed micellar solutions with particular reference to bile. Am J Med 1970; 49: 590-608
9. Paumgartner G, Reichen J, von Bergmann K, Preisig R. Elaboration of hepatocytic bile. Bull N Y Acad Med 1975; 51: 455-471
10. Danielsson H, Sjovall J. Bile acid metabolism. Annu Rev Biochem 1975; 44: 233-253
11. Reyes H. Review: intrahepatic cholestasis. A puzzling disorder of pregnancy. J Gastroenterol Hepatol 1997; 12: 211-216
12. Setchell KD, Street JM. Inborn errors of bile acid synthesis. Semin Liver Dis 1987; 7: 85-99
13. Poupon RE, Balkau B, Es chwege E, Poupon R. A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group. N Engl J Med 1991; 324: 1548-1554
14. Meier PJ, Stieger B. Bile salt transporters. Annu Rev Physiol 2002; 64: 635-661
15. Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003; 1609: 1-18
16. Hagenbuch B, Dawson P. The sodium bile salt cotransport family SLC10. Pflugers Arch 2004; 447: 566-570
17. Keppler D, Konig J. Hepatic secretion of conjugated drugs and endogenous substances. Semin Liver Dis 2000; 20: 265-272
18. Strautnieks SS, Bull LN, Knisely AS, Kocoshis SA, Dahl N, Arnell H, Sokal E, Dahan K, Childs S, Ling V, Tanner MS, Kagalwalla AF, Nemeth A, Pawlowska J, Baker A, Mieli-Vergani G, Freimer NB, Gardiner RM, Thompson RJ. A gene encoding a liver-specific ABC transporter is mutated in progressive familial intrahepatic cholestasis. Nat Genet 1998; 20: 233-238
19. Shitara Y, Sato H, Sugiyama Y. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol 2005; 45: 689-723
20. Klaassen CD. Biliary excretion of xenobiotics. CRC Crit Rev Toxicol 1975; 4: 1-30
21. Petzinger E, Geyer J. Drug transporters in pharmacokinetics. Naunyn Schmiedebergs Arch Pharmacol 2006; 372: 465-475
22. Kramer W, Wess G. Bile acid transport systems as pharmaceutical targets. Eur J Clin Invest 1996; 26: 715-732
23. Dominguez MF, Macias RI, Izco-Basurko I, de La Fuente A, Pascual MJ, Criado JM, Monte MJ, Yajeya J, Marin JJ. Low in vivo toxicity of a novel cisplatin-ursodeoxycholic derivative (Bamet-UD2) with enhanced cytostatic activity versus liver tumors. J Pharmacol Exp Ther 2001; 297: 1106-1112
24. Briz O, Macias RI, Vallejo M, Silva A, Serrano MA, Marin JJ. Usefulness of liposomes loaded with cytostatic bile acid derivatives to circumvent chemotherapy resistance of enterohepatic tumors. Mol Pharmacol 2003; 63: 742-750
25. Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science 1999; 284: 1362-1365
26. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, Lehmann JM. Bile acids: natural ligands for an orphan nuclear receptor. Science 1999; 284: 1365-1368
27. Wang H, Chen J, Hollister K, Sowers LC, Forman BM. Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999; 3: 543-553
28. Karpen SJ. Nuclear receptor regulation of hepatic function. J Hepatol 2002; 36: 832-850
29. Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005; 433: 397-412
30. Chiang JY. Bile acid regulation of gene expression: roles of nuclear hormone receptors. Endocr Rev 2002; 23: 443-463
31. Houten SM, Watanabe M, Auwerx J. Endocrine functions of bile acids. EMBO J 2006; 25: 1419-1425
32. Zollner G, Marschall HU, Wagner M, Trauner M. Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. Mol Pharm 2006; 3: 231-251
33. Arrese M, Trauner M, Ananthanarayanan M, Pizarro M, Solis N, Accatino L, Soroka C, Boyer JL, Karpen SJ, Miquel JF, Suchy FJ. Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat. J Hepatol 2003; 38: 148-55
34. Suchy FJ, Ananthanarayanan M. Bile salt excretory pump: biology and pathobiology. J Pediatr Gastroenterol Nutr 2006; 43 Suppl 1: S10-S16
35. Van Mil SW, Milona A, Dixon PH, Mullenbach R, Geenes VL, Chambers J, Shevchuk V, Moore GE, Lammert F, Glantz AG, Mattsson LA, Whittaker J, Parker MG, White R, Williamson C. Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy. Gastroenterology 2007; 133: 507-516
36. Arrese M, Macias RI, Briz O, Perez MJ, Marin JJ. Molecular pathogenesis of intrahepatic cholestasis of pregnancy. Expert Rev Mol Med 2008; 10: e9
37. Keitel V, Reinehr R, Gatsios P, Rupprecht C, Gorg B, Selbach O, Haussinger D, Kubitz R. The G-protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells. Hepatology 2007; 45: 695-704
38. Dent P, Fang Y, Gupta S, Studer E, Mitchell C, Spiegel S, Hylemon PB. Conjugated bile acids promote ERK1/2 and AKT activation via a pertussis toxin-sensitive mechanism in murine and human hepatocytes. Hepatology 2005; 42: 1291-1299
39. Kawamata Y, Fujii R, Hosoya M, Harada M, Yoshida H, Miwa M, Fukusumi S, Habata Y, Itoh T, Shintani Y, Hinuma S, Fujisawa Y, Fujino M. A G protein-coupled receptor responsive to bile acids. J Biol Chem 2003; 278: 9435-9440
40. Wimmer R, Hohenester S, Pusl T, Denk GU, Rust C, Beuers U. Tauroursodeoxycholic acid exerts anticholestatic effects by a cooperative cPKC{alpha}-/PKA-dependent mechanism in rat liver. Gut 2008; 57: 1448-1454
41. Wang L, Piguet AC, Schmidt K, Tordjmann T, Dufour JF. Activation of CREB by tauroursodeoxycholic acid protects cholangiocytes from apoptosis induced by mTOR inhibition. Hepatology 2005; 41: 1241-1251
42. Bogert PT, LaRusso NF. Cholangiocyte biology. Curr Opin Gastroenterol 2007; 23: 299-305
43. Ballatori N, Hammond CL, Cunningham JB, Krance SM, Marchan R. Molecular mechanisms of reduced glutathione transport: role of the MRP/ CFTR/ABCC and OATP/SLC21A families of membrane proteins. Toxicol Appl Pharmacol 2005; 204: 238-255
44. Arias IM. Hepatic aspects of bilirubin metabolism. Annu Rev Med 1966; 17: 257-274
45. Wolkoff AW. Hepatocellular sinusoidal membrane organic anion transport and transporters. Semin Liver Dis 1996; 16: 121-127
46. Oude Elferink RP, Meijer DK, Kuipers F, Jansen PL, Groen AK, Groothuis GM. Hepatobiliary secretion of organic compounds; molecular mechanisms of membrane transport. Biochim Biophys Acta 1995; 1241: 215-268
47. Ostrow JD. Photochemical and biochemical basis of the treatment of neonatal jaundice. Prog Liver Dis 1972; 4: 447-462
48. Fevery J, Blanckaert N, Heirwegh KP, De Groote J. Bilirubin conjugates: formation and detection. Prog Liver Dis 1976; 5: 183-214
49. Coleman R. Bile salts and biliary lipids. Biochem Soc Trans 1987; 15 Suppl: 68S-80S
50. Berenson MM, Marin JJ, Larsen R, Avner D. Effect of bile acids on hepatic protoporphyrin metabolism in perfused rat liver. Gastroenterology 1987; 93: 1086-1093
51. Vore M. Canalicular transport: discovery of ATP-dependent mechanisms. Toxicol Appl Pharmacol 1993; 118: 2-7